Viewing nowCombinationVigetin Tablet 10/20
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.

MFDS item code 201803868 · Approved 2018.09.28 · Insurance code 662504020
Improvement of mixed dyslipidemia and hypercholesterolemia (primary and homozygous familial)
This medication helps to lower total cholesterol, LDL-cholesterol, Apo B protein, and triglycerides in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial hypercholesterolemia, as well as mixed hyperlipidemia, while increasing HDL-cholesterol. It may be used in conjunction with or as an alternative treatment to other therapies for patients with homozygous familial hypercholesterolemia to reduce LDL-cholesterol levels. This medication should be taken alongside an appropriate diet, and it is important to administer it when diet or non-pharmacological treatment is insufficient. Before starting treatment, secondary causes such as diabetes and hypothyroidism should be assessed and treated if necessary. Additionally, when acute coronary events occur, blood lipid levels should be checked at the time of admission or within 24 hours to inform the treatment plan, and this medication is used to reduce the risk of atherosclerotic vascular disease related to hypercholesterolemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient’s baseline LDL-cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. For patients who require a less pronounced reduction in LDL-cholesterol, treatment may be started at 10/10mg once daily. After starting treatment with this drug or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not suitable. Administration to patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug at 10/20mg once daily in the evening. If this drug is administered at a higher dose to these patients, it should be used with caution and they should be closely monitored (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 6. Drug Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.
This medication is used to lower blood cholesterol levels. There is a risk of muscle abnormalities; if symptoms such as muscle pain or weakness occur, notify a doctor immediately. Caution is especially needed with high-dose use, as the risk of muscle damage may increase. This medication may affect liver function, and it should not be administered in cases of liver disease or elevated liver enzymes. Women who are pregnant or breastfeeding should not take this medication, and women planning to become pregnant should consult a doctor before taking it. There are many potential drug interactions; taking it with certain antifungals, antibiotics, antivirals, immunosuppressants, etc., may increase the risk of muscle damage, so it is essential to inform your doctor about any other medications you are taking. This medication contains lactose, so individuals with lactose intolerance should use caution. Elderly patients or those with kidney disease require more careful monitoring while taking this medication. Regular blood tests to check liver function and muscle condition are recommended during treatment. It is advisable to avoid consuming this medication with grapefruit juice or high-dose niacin. In case of overdose, there is no specific antidote, and immediate medical attention should be sought. This medication is used limitedly in children; pediatric and adolescent patients should take it under medical supervision.
Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, cholelithiasis, cholecystitis, skin and mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, drug reactions with systemic symptoms, erythema multiforme, drug-induced liver injury, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, taste disturbances, oculomotor disorders, facial muscle weakness, tremor, peripheral neuropathy, peripheral nerve palsy, mental disorders, anxiety, sleep disorders, insomnia, nightmares, cognitive impairment, severe muscle weakness, ophthalmoplegia, interstitial lung disease, lupus-like erythematosus syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant hepatic necrosis, liver cancer, alopecia, various skin changes, lichenoid drug rash, gynecomastia, decreased libido, sexual dysfunction, ophthalmoplegia, anemia, elevated aminotransferase levels, elevated ALP, elevated ɤ-GT, elevated bilirubin levels, thyroid dysfunction, elevated serum creatine kinase, transient liver function test abnormalities, increased HbA1c, elevated fasting blood sugar levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain room temperature between 1 and 30 degrees Celsius. This helps to preserve the medication's effectiveness for a long time.
White to off-white, bilaterally convex rectangular tablet
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.